Statins, haemostatic factors and thrombotic risk

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Hematology

Background:

• Statins are widely used for cholesterol reduction.
• Beyond lipid-lowering, statins may influence hemostasis and thrombosis.
• This review updates the effects of statins on hemostasis and clinical outcomes.

Purpose of the Study:

• To review the impact of statin treatment on hemostasis markers.
• To assess statin effects on platelet function.
• To evaluate statin influence on thrombosis-related outcomes.

Main Methods:

• Literature review of studies on statins, hemostasis, and thrombosis.
• Analysis of effects on coagulation factors and fibrinolysis.
• Examination of clinical data on venous thromboembolism and acute coronary syndrome events.

Main Results:

• Statins modulate coagulation factors, inhibiting coagulation and enhancing fibrinolysis.
• Statin use is associated with reduced venous thromboembolism incidence in observational studies.
• Early statin initiation post-acute coronary syndrome may offer short-term thrombotic event prevention, but data are inconsistent.

Conclusions:

• Statins exhibit antithrombotic effects by influencing hemostatic factors.
• Evidence for statin use in venous thromboembolism prevention is inconsistent.
• The role of statins in early vascular event prevention post-ACS requires further investigation.